GDM has been established as a strong predictor for T2D, with the risk particularly increased amongst women affected by GDM if persistent fasting hyperglycaemia occurred in pregnancy, insulin therapy was required to treat GDM, an elevated BMI was present prior to pregnancy or if GDM recurred in subsequent pregnancies [90,91,92,93]. This evidence concerns the gene INS and gestational diabetes.